Remove 2023 Remove Doctors Remove Testimonials Remove Treatment
article thumbnail

FDA Returns Disappointing News for ALS Stem Cell Therapy

PLOS: DNA Science

Also recently, FDA’s Cellular, Tissue, and Gene Therapies Advisory Committe turned down a stem cell treatment for amyotrophic lateral sclerosis, aka ALS, Lou Gehrig’s disease, or motor neuron disease. The only treatment for ALS is a drug, Riluzole , taken as a tablet or a film. The pace though varies quite a lot.

Therapies 104
article thumbnail

Another RICOdiculous Decision

Drug & Device Law

Yet what the plaintiffs were claiming is that, despite Actos’ undisputed effectiveness as a diabetes treatment, no TPP in the country would have purchased it for that purpose because of the 3/10,000 bladder cancer increased risk. 3d , 2023 WL 4191651 (C.D. PATDC82 II , 2023 WL 4191651, at *3. 2023 WL 4191651, at *8.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Federal Court Calls Out—and Enjoins—Anti-Trans Bigotry

Drug & Device Law

Ladapo , 2023 WL 3833848 (N.D. 2023), appeared in our daily search results because it briefly addresses off-label use of prescription drugs. 2023 WL 3833848, at *3. There are well-established standards of care for treatment of gender dysphoria.” Doe , 2023 WL 3833848, at *2. 2023 WL 3833848, at *2.

Doctors 122
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

In 2023 there seemed to be an unusually large number of other decisions that are likely to have a substantial impact on what we or our clients do, but involve either different products, non-product claims, or both. In 2023, these include United States ex rel. 2023) (no medical monitoring in Delaware) ( here ); Brown v.

article thumbnail

GranuFlo/NaturaLyte MDL Substantive Rulings – Better Late Than Never

Drug & Device Law

3d , 2023 WL 5807340 (D. G/N , 2023 WL 5807340, at *1. G/N , 2023 WL 5807340, at *9 (plaintiffs’ experts “conducted no independent studies” and “explicitly relied on” the memo as the basis of their opinions). Until a little while ago. Those plaintiffs were in trouble because all of their experts slavishly relied on the memo.

article thumbnail

Med-Mal Plaintiff Expert Standard of Care Opinion Unnecessary Due to FDA Warnings

Drug & Device Law

Sometimes expert testimony bolsters the warnings story for one or both sides, but not always. 2023 WL 3589654 (Ariz. May 23, 2023). The doctor prescribed Cipro for the plaintiff after a urological procedure. If a doctor’s treatment of a patient is negligent, that usually spells medical malpractice.

FDA 59
article thumbnail

S.D. Alabama Puts Surgeons Before Sales Representatives

Drug & Device Law

Defining “inconsistency” liberally, plaintiffs try to use sales reps to get around the learned intermediary doctrine often without much more evidence than that the sales rep visited the prescribing doctor. A step in the right direction of keeping the doctors in the foreground of the analysis. Depuy Orthopaedics, Inc. LEXIS 54471 (N.D.